SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001346302-21-000060
Filing Date
2021-06-08
Accepted
2021-06-08 19:09:30
Documents
1
Period of Report
2021-06-08

Document Format Files

Seq Description Document Type Size
1 FORM 4 wf-form4_162319374400964.html 4  
1 FORM 4 wf-form4_162319374400964.xml 4 3892
  Complete submission text file 0001346302-21-000060.txt   5305
Mailing Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601
Business Address 180 NORTH LASALLE STREET SUITE 1600 CHICAGO IL 60601 844-445-5704
XERIS PHARMACEUTICALS INC (Issuer) CIK: 0001346302 (see all company filings)

IRS No.: 203352427 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O XERIS PHARMACEUTICALS 180 N. LASALLE ST., STE. 1800 CHICAGO IL 60601
Business Address
HALKUFF DAWN (Reporting) CIK: 0001743658 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-38536 | Film No.: 211003507